Pathway Genomics Corporation operates a clinical laboratory providing comprehensive genomic testing services including general health and wellness, liquid biopsy, pharmacogenomics, hereditary cancer risk, and carrier screening. The company serves physicians and patients across 40+ countries with CLIA and CAP accreditation.
Pathway Genomics has been acquired
This company is no longer available on our private secondary market.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2008
Employees
50–200
Total Funding
$43M
2 rounds
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Total raised $43M across 2 rounds
Last updated 09-29-2026
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| Jan 5, 2016 | Series E | $40M | — | IBM Ventures |
| Jul 1, 2009 | Series A | $3M | — | Founders Fund |
Jim Plante
Founder and CEO
Competitor list is illustrative and may be incomplete, stale, or erroneous.
23andMe
Consumer genetics and personalized health company offering direct-to-consumer DNA testing and health insights
Invitae
Medical genetics company providing comprehensive genetic testing services ordered by healthcare providers
Color Genomics
Precision medicine company providing genetic testing for cancer risk and other inherited conditions
Foundation Medicine
Genomics company specializing in comprehensive genomic profiling for cancer care and treatment selection
Fulgent Genetics
Clinical genetic testing and sequencing company providing comprehensive diagnostic testing services
Helix
Genomics platform and digital health company providing consumer DNA testing and health insights
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.